Evidence for net renal tubule oxalate secretion in patients with calcium kidney stones

American Journal of Physiology - Renal Physiology

Volumn 300, Issue 2, 2011, Pages

  Bergsland, Kristin J ^a   Zisman, Anna L ^a   Asplin, John R ^b   Worcester, Elaine M ^a   Coe, Fredric L ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b LithoLink Corporation   (United States)

Author keywords

Bariatric stone former; Hypercalciuria; Nephrolithiasis; Plasma oxalate

Indexed keywords

CALCIUM OXALATE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; HYPEROXALURIA; IDIOPATHIC HYPERCALCIURIA; KIDNEY TUBULE EXCRETION; MALE; NEPHROLITHIASIS; PRIORITY JOURNAL; URINARY EXCRETION;

EID: 79551511753     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00411.2010     Document Type: Article

References (44)

1. Asplin JR, Coe FL. Hyperoxaluria in kidney stone formers treated with modern bariatric surgery. J Urol 177: 565-569, 2007.
2. Baggio B, Gambaro G, Favaro S, Borsatti A. Prevalence of hyperoxaluria in idiopathic calcium oxalate kidney stone disease. Nephron 35: 11-14, 1983.
3. Bergsland KJ, Coe FL, Gillen DL, Worcester EM. A test of the hypothesis that the collecting duct calcium-sensing receptor limits rise of urine calcium molarity in hypercalciuric calcium kidney stone formers. Am J Physiol Renal Physiol 297: F1017-F1023, 2009.
4. Berndt T, Thomas LF, Craig TA, Sommer S, Li X, Bergstralh EJ, Kumar R. Evidence for a signaling axis by which intestinal phosphate rapidly modulates renal phosphate reabsorption. Proc Natl Acad Sci USA 104: 11085-11090, 2007.
5. Coe FL, Parks JH, Evan AP, Worcester EM. Pathogenesis and treatment of nephrolithiasis. In: Seldin and Giebisch's The Kidney (4th ed.), edited by Alpern RJ and Hebert SC. Burlington, MA: Academic, 2008, p. 1945-1977.
6. Curhan GC, Willett WC, Rimm EB, Stampfer MJ. A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. N Engl J Med 328: 833-838, 1993.
7. Curhan GC, Willett WC, Speizer FE, Stampfer MJ. Twenty-four-hour urine chemistries and the risk of kidney stones among women and men. Kidney Int 59: 2290-2298, 2001.
8. Harris AH, Freel RW, Hatch M. Serum oxalate in human beings and rats as determined with the use of ion chromatography. J Lab Clin Med 144: 45-52, 2004.
9. Hesse A, Schneeberger W, Engfeld S, Von Unruh GE, Sauerbruch T. Intestinal hyperabsorption of oxalate in calcium oxalate stone formers: application of a new test with [13C2]oxalate. J Am Soc Nephrol 10, Suppl 14: S329-S333, 1999.
10. Holmes RP, Ambrosius WT, Assimos DG. Dietary oxalate loads and renal oxalate handling. J Urol 174: 943-947, 2005.
11. Holmes RP, Assimos DG. The impact of dietary oxalate on kidney stone formation. Urol Res 32: 311-316, 2004.
12. Holmes RP, Assimos DG, Goodman HO. Genetic and dietary influences on urinary oxalate excretion. Urol Res 26: 195-200, 1998.
13. Holmes RP, Goodman HO, Assimos DG. Contribution of dietary oxalate to urinary oxalate excretion. Kidney Int 59: 270-276, 2001.
14. Holmes RP, Goodman HO, Assimos DG. Dietary oxalate and its intestinal absorption. Scanning Microsc 9: 1109-1118, 1995.
15. Hoppe B, Langman CB. A United States survey on diagnosis, treatment, and outcome of primary hyperoxaluria. Pediatr Nephrol 18: 986-991, 2003.
16. Jiang Z, Asplin JR, Evan AP, Rajendran VM, Velazquez H, Nottoli TP, Binder HJ, Aronson PS. Calcium oxalate urolithiasis in mice lacking anion transporter Slc26a6. Nat Genet 38: 474-478, 2006.
17. Kasidas GP, Rose GA. Measurement of plasma oxalate in healthy subjects and in patients with chronic renal failure using immobilised oxalate oxidase. Clin Chim Acta 154: 49-58, 1986.
18. Kaufman DW, Kelly JP, Curhan GC, Anderson TE, Dretler SP, Preminger GM, Cave DR. Oxalobacter formigenes may reduce the risk of calcium oxalate kidney stones. J Am Soc Nephrol 19: 1197-1203, 2008.
19. Knight J, Holmes RP, Assimos DG. Intestinal and renal handling of oxalate loads in normal individuals and stone formers. Urol Res 35: 111-117, 2007.
20. Knight J, Jiang J, Assimos DG, Holmes RP. Hydroxyproline ingestion and urinary oxalate and glycolate excretion. Kidney Int 70: 1929-1934, 2006.
21. Krishnamurthy MS, Hruska KA, Chandhoke PS. The urinary response to an oral oxalate load in recurrent calcium stone formers. J Urol 169: 2030-2033, 2003.
22. Ladwig PM, Liedtke RR, Larson TS, Lieske JC. Sensitive spectrophotometric assay for plasma oxalate. Clin Chem 51: 2377-2380, 2005.
23. Laminski NA, Meyers AM, Kruger M, Sonnekus MI, Margolius LP. Hyperoxaluria in patients with recurrent calcium oxalate calculi: dietary and other risk factors. Br J Urol 68: 454-458, 1991.
24. Lemann J Jr, Pleuss JA, Worcester EM, Hornick L, Schrab D, Hoffmann RG. Urinary oxalate excretion increases with body size and decreases with increasing dietary calcium intake among healthy adults. Kidney Int 49: 200-208, 1996.
25. Pak CY, Adams-Huet B, Poindexter JR, Pearle MS, Peterson RD, Moe OW. Rapid communication: relative effect of urinary calcium and oxalate on saturation of calcium oxalate. Kidney Int 66: 2032-2037, 2004.
26. Patel BN, Passman CM, Fernandez A, Asplin JR, Coe FL, Kim SC, Lingeman JE, Assimos DG. Prevalence of hyperoxaluria after bariatric surgery. J Urol 181: 161-166, 2009.
27. Porowski T, Konstantynowicz J, Zoch-Zwierz W. A need to establish normative data for plasma oxalates. Am J Kidney Dis 51: 1071-1072, 2008.
28. Porowski T, Zoch-Zwierz W, Konstantynowicz J, Korzeniecka-Kozerska A, Michaluk-Skutnik J, Porowska H. Reference values of plasma oxalate in children and adolescents. Pediatr Nephrol 23: 1787-1794, 2008.
29. Schwille PO, Hanisch E, Scholz D. Postprandial hyperoxaluria and intestinal oxalate absorption in idiopathic renal stone disease. J Urol 132: 650-655, 1984.
30. Schwille PO, Manoharan M, Rumenapf G, Wolfel G, Berens H. Oxalate measurement in the picomol range by ion chromatography: values in fasting plasma and urine of controls and patients with idiopathic calcium urolithiasis. J Clin Chem Clin Biochem 27: 87-96, 1989.
31. Sidhu H, Schmidt ME, Cornelius JG, Thamilselvan S, Khan SR, Hesse A, Peck AB. Direct correlation between hyperoxaluria/oxalate stone disease and the absence of the gastrointestinal tract-dwelling bacterium Oxalobacter formigenes: possible prevention by gut recolonization or enzyme replacement therapy. J Am Soc Nephrol 10, Suppl 14: S334-S340, 1999.
32. Siener R, Ebert D, Nicolay C, Hesse A. Dietary risk factors for hyperoxaluria in calcium oxalate stone formers. Kidney Int 63: 1037-1043, 2003.
33. Sinha MK, Collazo-Clavell ML, Rule A, Milliner DS, Nelson W, Sarr MG, Kumar R, Lieske JC. Hyperoxaluric nephrolithiasis is a complication of Roux-en-Y gastric bypass surgery. Kidney Int 72: 100-107, 2007.
34. Taylor EN, Curhan GC. Determinants of 24-hour urinary oxalate excretion. Clin J Am Soc Nephrol 3: 1453-1460, 2008.
35. Taylor EN, Curhan GC. Oxalate intake and the risk for nephrolithiasis. J Am Soc Nephrol 18: 2198-2204, 2007.
36. Troxel SA, Sidhu H, Kaul P, Low RK. Intestinal Oxalobacter formigenes colonization in calcium oxalate stone formers and its relation to urinary oxalate. J Endourol 17: 173-176, 2003.
37. von Unruh GE, Bell AE, Hesse A. Effect of oxalate test dose size on absolute and percent oxalate absorption. Isotopes Environ Health Stud 42: 107-112, 2006.
38. 13C2]oxalate absorption test. J Urol 175: 1711-1715, 2006.
39. Wang T, Egbert AL Jr, Abbiati T, Aronson PS, Giebisch G. Mechanisms of stimulation of proximal tubule chloride transport by formate and oxalate. Am J Physiol Renal Fluid Electrolyte Physiol 271: F446-F450, 1996.
40. Wilson DM, Liedtke RR. Modified enzyme-based colorimetric assay of urinary and plasma oxalate with improved sensitivity and no ascorbate interference: reference values and sample handling procedures. Clin Chem 37: 1229-1235, 1991.
41. Worcester EM, Coe FL, Evan AP, Bergsland KJ, Parks JH, Willis LR, Clark DL, Gillen DL. Evidence for increased postprandial distal nephron calcium delivery in hypercalciuric stone-forming patients. Am J Physiol Renal Physiol 295: F1286-F1294, 2008.
42. Worcester EM, Gillen DL, Evan AP, Parks JH, Wright K, Trumbore L, Nakagawa Y, Coe FL. Evidence that postprandial reduction of renal calcium reabsorption mediates hypercalciuria of patients with calcium nephrolithiasis. Am J Physiol Renal Physiol 292: F66-F75, 2007.
43. Worcester EM, Nakagawa Y, Bushinsky DA, Coe FL. Evidence that serum calcium oxalate supersaturation is a consequence of oxalate retention in patients with chronic renal failure. J Clin Invest 77: 1888-1896, 1986.
44. Zimmermann DJ, Hesse A, von Unruh GE. Influence of a high-oxalate diet on intestinal oxalate absorption. World J Urol 23: 324-329, 2005.